AI Article Synopsis

  • Milk fat globule membrane (MFGM) is important for infant development but is not present in standard infant formulas; this study aimed to assess the safety of adding MFGM to formula for infants aged 0 to 12 months.
  • In a trial involving 375 infants, those on MFGM-enriched formula experienced fewer instances of diarrhea and soft stools compared to those on standard formula, indicating better digestive tolerance.
  • Overall, MFGM-enriched formula was found to be safe and well-tolerated, although breast-fed infants showed better growth and health outcomes compared to both formula-fed groups.

Article Abstract

Background: Milk fat globule membrane (MFGM), natural to breast milk, is essential for neonatal development, but lacking from standard infant formulas.

Objectives: To evaluate the safety and tolerability of MFGM supplementation in formula for infants 0 to 12 months.

Methods: In a prospective, multicentre, double-blind, randomized trial, healthy term infants were randomized to a standard formula (SF, n = 104) or an MFGM-enriched formula (MF, n = 108) for 6 months and a corresponding follow-on formula until 12 months. Exclusively breast-fed infants (n = 206) were recruited as the reference group (BFR). Tolerance and safety events were recorded continuously. Anthropometric measurements were assessed at enrolment, 42 days and 4, 6, 8 and 12 months.

Results: Infants (n = 375) completed the study with average dropout of < 20%. Stool frequency, color, and consistency between SF and MF were not significantly different throughout, except the incidence of loose stools in MF at 6 months being lower than for SF (odds ratio 0.216, P < 0.05) and the frequency of green-colored stools at 12 months being higher in MF (CI 95%, odds ratio 8.92, P < 0.05). The BFR had a higher frequency of golden stools and lower rate of green stools (4-6 months) than the two formula-fed groups (P < 0.05). SF displayed more diarrhoea (4.8%) than MF (1%) and BFR (1%) at the 8-month visit (P < 0.05). BFR (0-1%) had significantly less (P < 0.05) lower respiratory infections than MF (4.6-6.5%) and SF (2.9-5.8%) at 6- and 8-months, respectively. Formula intake, frequency of spit-up/vomiting or poor sleep were similar between SF and MF. Growth rate (g/day) was similar at 4, 6, 8 and 12 months between the 3 groups, but growth rate for BFR was significantly higher than for SF and MF at 42 days (95% CI, P = 0.001).

Conclusions: MFGM-enriched formula was safe and well-tolerated in healthy term infants between 0 and 12 months, and total incidences of adverse events were similar to that for the SF group. A few differences in formula tolerance were observed, however these differences were not in any way related to poor growth.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347101PMC
http://dx.doi.org/10.1186/s12887-022-03507-8DOI Listing

Publication Analysis

Top Keywords

milk fat
8
fat globule
8
infants
5
safety tolerance
4
tolerance assessment
4
assessment milk
4
globule membrane-enriched
4
membrane-enriched infant
4
infant formulas
4
formulas healthy
4

Similar Publications

The increased use of dairy fat in various applications is facilitated by its fractionation into hard and liquid fractions. Herein, the fractionation of bovine ghee and buffalo ghee was investigated, and triacylglycerol (TAG) profiles of milk fat fractions and 2 categories of infant formulas fat were quantified by using ultra-performance convergence chromatography quadrupole time-of-flight mass spectrometry (UPC-Q-TOF-MS) using carbon dioxide as the mobile phase. Furthermore, the thermal behavior of the different samples was evaluated, and tocopherols content was also quantified.

View Article and Find Full Text PDF

We aimed to evaluate the effects of prepartum supplementation of different I sources (Ascophyllum nodosum [ASCO] meal and ethylenediamine dihydroiodide [EDDI]) on colostrum yield of cows, and blood concentrations of glucose, BHB, and thyroid hormones and growth of dairy calves. Forty multiparous Holstein cows were blocked by lactation number and expected calving date and assigned to 1 of 4 treatments 28 d before parturition: (1) EDDI supplemented (11 mg/d) to a basal diet to meet the NRC (2001) I concentration of 0.5 mg of I/kg of DMI (control = CON [0 g/d of ASCO meal]; actual I concentration = 0.

View Article and Find Full Text PDF

Forty-eight multiparous Holstein cows were used in a randomized complete block design and assigned to one of 4 treatments in a 2x2 factorial arrangement of treatments to determine the effects of supplemental palmitic acid (C16:0) and chromium (Cr) on production responses of early-lactation cows. During the fresh period (FR; 1-24 d in milk), cows were fed one of 4 treatments: (1) a diet containing no supplemental C16:0 or Cr (CON); (2) diet supplemented with an 85% C16:0-enriched supplement (PA); (3) diet supplemented with Cr-propionate (CR); and (4) diet supplemented with a C16:0-enriched supplement and Cr-propionate (PACR). The C16:0-enriched supplement was added at 1.

View Article and Find Full Text PDF

This study employed proteomics and phosphoproteomics to compare protein expression and phosphorylation modifications in the milk fat globule membrane (MFGM) of human and bovine mature milk. A total of 410 proteins and 73 phosphorylation sites on 49 proteins were identified in the MFGM of bovine and human mature milk, respectively. Differential analysis revealed 40 differentially expressed proteins and 8 differentially phosphorylated sites, followed by bioinformatics analysis.

View Article and Find Full Text PDF

The improved growth performance of calves at weaning results from an effective pre-weaning feeding strategy. The type and pasteurization process of liquid feed are among the most variable feeding practices affecting calves' growth and health. In previous studies that compared waste milk (WM) vs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!